Leandro Cerchietti Selected Research

Leandro Cerchietti Research Topics

Disease

33	Neoplasms (Cancer) 03/2024 - 02/2007
22	Lymphoma (Lymphomas) 01/2024 - 12/2004
12	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022 - 12/2004
7	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 06/2010
5	Leukemia 10/2020 - 10/2011
3	T-Cell Lymphoma (Lymphoma, T Cell) 01/2022 - 01/2015
3	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 06/2020 - 11/2016
2	Multiple Myeloma 01/2023 - 01/2018
2	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 06/2020 - 11/2016
2	Oncogene Addiction 10/2019 - 01/2016
2	Lung Neoplasms (Lung Cancer) 01/2017 - 04/2008
2	Breast Neoplasms (Breast Cancer) 12/2014 - 05/2009
2	Triple Negative Breast Neoplasms 07/2014 - 05/2009
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2011 - 09/2011
1	Inflammation (Inflammations) 01/2023
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 01/2022
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2022
1	Hypothyroidism 01/2022
1	Frailty 01/2022
1	Brain Neoplasms (Brain Tumor) 11/2021
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 11/2018
1	Genetic Translocation (Chromosomal Translocation) 01/2016
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 12/2015
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2015

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 11/2015 - 09/2011
5	Peptides (Polypeptides)IBA 12/2015 - 12/2004
4	IntegrinsIBA 01/2022 - 01/2015
4	LigandsIBA 07/2017 - 08/2014
4	6- amino- 8- ((6- iodo- 1,3- benzodioxol- 5- yl)thio)- N- (1- methylethyl)- 9H-purine-9-propanamineIBA 11/2015 - 05/2009
3	Azacitidine (5 Azacytidine)FDA Link 01/2022 - 01/2016
3	Lysine (L-Lysine)FDA Link 10/2019 - 01/2018
3	Histone Deacetylase InhibitorsIBA 02/2018 - 07/2014
2	Messenger RNA (mRNA)IBA 10/2023 - 04/2019
2	cc-486IBA 01/2023 - 01/2022
2	Sirtuin 3IBA 01/2022 - 10/2019
2	Antineoplastic Agents (Antineoplastics)IBA 01/2022 - 02/2018
2	Adenosine Triphosphate (ATP)IBA 11/2021 - 11/2015
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 09/2013
2	Eukaryotic Initiation Factor-4EIBA 10/2020 - 02/2016
2	EnzymesIBA 04/2019 - 07/2014
2	PanobinostatIBA 02/2018 - 12/2015
2	HydrogelsIBA 07/2017 - 12/2015
2	Biocompatible Materials (Biomaterials)IBA 07/2017 - 12/2015
2	Anaplastic Lymphoma KinaseIBA 11/2016 - 04/2011
2	ProteomeIBA 08/2014 - 09/2011
2	Transcription Factors (Transcription Factor)IBA 07/2014 - 02/2007
2	Glucose (Dextrose)FDA LinkGeneric 02/2014 - 07/2013
2	Oxygen (Dioxygen)IBA 02/2014 - 07/2013
2	Tyrosine Kinase InhibitorsIBA 06/2013 - 10/2011
2	Oncogene Proteins (Oncogene Protein)IBA 09/2011 - 05/2009
1	ChromatinIBA 03/2024
1	RibonucleoproteinsIBA 01/2024
1	Histamine H4 ReceptorsIBA 01/2022
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2022
1	Bexarotene (LGD1069)FDA Link 01/2022
1	AnthracyclinesIBA 01/2022
1	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2022
1	Amino Acids FDA Link 01/2022
1	Untranslated RNA (Noncoding RNA)IBA 01/2022
1	Retinoid X Receptors (Retinoid X Receptor)IBA 01/2022
1	Arginine (L-Arginine)FDA Link 11/2021
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 11/2021
1	Nitric Oxide Synthase (NO Synthase)IBA 11/2021
1	Lactic Acid (Lactate)FDA LinkGeneric 11/2021
1	Multiprotein ComplexesIBA 10/2021
1	Janus Kinase InhibitorsIBA 06/2020
1	ruxolitinibIBA 06/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2019
1	Thyroid HormonesIBA 04/2019
1	Cytotoxins (Cytolysins)IBA 01/2019
1	Lenalidomide (CC 5013)FDA Link 11/2018
1	Rituximab (Mabthera)FDA Link 11/2018
1	Choline (Choline Chloride)IBA 02/2018
1	Histones (Histone)IBA 01/2018
1	Cell Surface ReceptorsIBA 07/2017
1	Small Interfering RNA (siRNA)IBA 06/2017
1	Drug CombinationsIBA 01/2017
1	obatoclaxIBA 01/2017
1	OTX015IBA 11/2016
1	RNA (Ribonucleic Acid)IBA 02/2016
1	Decitabine FDA Link 01/2016
1	Vorinostat FDA Link 01/2016
1	Indicators and Reagents (Reagents)IBA 12/2015
1	Syk KinaseIBA 12/2015
1	Protein Isoforms (Isoforms)IBA 11/2015
1	ibrutinibIBA 11/2015
1	AICA ribonucleotide (ZMP)IBA 11/2015
1	Excipients (Suspending Agents)IBA 11/2015
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 11/2015
1	Progesterone Receptors (Progesterone Receptor)IBA 12/2014
1	Progestins (Progestagens)IBA 12/2014
1	Cyclin A2IBA 12/2014
1	Biomarkers (Surrogate Marker)IBA 12/2014

Therapy/Procedure

19	Therapeutics 01/2022 - 02/2007
7	Drug Therapy (Chemotherapy) 04/2019 - 04/2008
5	Immunotherapy 03/2024 - 09/2015
2	Radiotherapy 11/2021 - 04/2008
1	Breast Implants (Breast Implant) 06/2020
1	Precision Medicine 06/2020